$XBIT: XBiotech was $25 last week before the news. The company reported that it has successfully completed a European Phase III study of Xilonix™ for the treatment of advanced colorectal cancer http://xbiotech.com/clinical/colorectal-cancer.php and they also made a deal with largest drug maker in Israel to produce and sell the cancer drug in Israel for big chunk of cash in front and going forward. FDA approval is in process and FDA by passed the phase III meeting to get to the final approval as soon as possible. You think, the stock should go up, but did not. Since the news came out last weekend, new investors did not see the news and shareholders got frastrated and sold there shares for 40% lower. Now is time to buy and ride this up. Good luck to you and if you make lot of money on this, drop me a note.